Literature DB >> 33856885

COVID-19 and the Drug Overdose Crisis: Uncovering the Deadliest Months in the United States, January‒July 2020.

Joseph Friedman1, Samir Akre1.   

Abstract

Objectives. To determine the magnitude of increases in monthly drug-related overdose mortality during the COVID-19 pandemic in the United States. Methods. We leveraged provisional records from the Centers for Disease Control and Prevention provided as rolling 12-month sums, which are helpful for smoothing, yet may mask pandemic-related spikes in overdose mortality. We cross-referenced these rolling aggregates with previous monthly data to estimate monthly drug-related overdose mortality for January through July 2020. We quantified historical errors stemming from reporting delays and estimated empirically derived 95% prediction intervals (PIs). Results. We found that 9192 (95% PI = 8988, 9397) people died from drug overdose in May 2020-making it the deadliest month on record-representing a 57.7% (95% PI = 54.2%, 61.2%) increase over May 2019. Most states saw large-magnitude increases, with the highest in West Virginia, Kentucky, and Tennessee. We observed low concordance between rolling 12-month aggregates and monthly pandemic-related shocks. Conclusions. Unprecedented increases in overdose mortality occurred during the pandemic, highlighting the value of presenting monthly values alongside smoothed aggregates for detecting shocks. Public Health Implications. Drastic exacerbations of the US overdose crisis warrant renewed investments in overdose surveillance and prevention during the pandemic response and postpandemic recovery efforts.

Entities:  

Mesh:

Year:  2021        PMID: 33856885      PMCID: PMC8493145          DOI: 10.2105/AJPH.2021.306256

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   11.561


  21 in total

1.  Overdose-Related Cardiac Arrests Observed by Emergency Medical Services During the US COVID-19 Epidemic.

Authors:  Joseph Friedman; Leo Beletsky; David L Schriger
Journal:  JAMA Psychiatry       Date:  2021-05-01       Impact factor: 21.596

2.  Is the Prescription Opioid Epidemic a White Problem?

Authors:  Helena Hansen; Julie Netherland
Journal:  Am J Public Health       Date:  2016-12       Impact factor: 9.308

3.  The Opioid Crisis in Black Communities.

Authors:  Keturah James; Ayana Jordan
Journal:  J Law Med Ethics       Date:  2018-06       Impact factor: 1.718

4.  Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose.

Authors:  Maya Doe-Simkins; Alexander Y Walley; Andy Epstein; Peter Moyer
Journal:  Am J Public Health       Date:  2009-05       Impact factor: 9.308

5.  Trends in US Emergency Department Visits for Mental Health, Overdose, and Violence Outcomes Before and During the COVID-19 Pandemic.

Authors:  Kristin M Holland; Christopher Jones; Alana M Vivolo-Kantor; Nimi Idaikkadar; Marissa Zwald; Brooke Hoots; Ellen Yard; Ashley D'Inverno; Elizabeth Swedo; May S Chen; Emiko Petrosky; Amy Board; Pedro Martinez; Deborah M Stone; Royal Law; Michael A Coletta; Jennifer Adjemian; Craig Thomas; Richard W Puddy; Georgina Peacock; Nicole F Dowling; Debra Houry
Journal:  JAMA Psychiatry       Date:  2021-04-01       Impact factor: 21.596

6.  "I probably got a minute": Perceptions of fentanyl test strip use among people who use stimulants.

Authors:  Megan K Reed; Alexis M Roth; Loni P Tabb; Ali K Groves; Stephen E Lankenau
Journal:  Int J Drug Policy       Date:  2021-02-12

7.  Tackling the overdose crisis: The role of safe supply.

Authors:  Andrew Ivsins; Jade Boyd; Leo Beletsky; Ryan McNeil
Journal:  Int J Drug Policy       Date:  2020-05-01

8.  Signal of increased opioid overdose during COVID-19 from emergency medical services data.

Authors:  Svetla Slavova; Peter Rock; Heather M Bush; Dana Quesinberry; Sharon L Walsh
Journal:  Drug Alcohol Depend       Date:  2020-07-10       Impact factor: 4.492

9.  Steep increases in fentanyl-related mortality west of the Mississippi River: Recent evidence from county and state surveillance.

Authors:  Chelsea L Shover; Titilola O Falasinnu; Candice L Dwyer; Nayelie Benitez Santos; Nicole J Cunningham; Rohan B Freedman; Noel A Vest; Keith Humphreys
Journal:  Drug Alcohol Depend       Date:  2020-09-28       Impact factor: 4.492

10.  The COVID-19 pandemic and health inequalities.

Authors:  Clare Bambra; Ryan Riordan; John Ford; Fiona Matthews
Journal:  J Epidemiol Community Health       Date:  2020-06-13       Impact factor: 3.710

View more
  31 in total

1.  Limited access to pharmacy-based naloxone in West Virginia: Results from a statewide purchase trial.

Authors:  Robin A Pollini; Jenny E Ozga; Rebecca Joyce; Ziming Xuan; Alexander Y Walley
Journal:  Drug Alcohol Depend       Date:  2021-12-31       Impact factor: 4.492

2.  Implementation of Safe Supply Alternatives During Intersecting COVID-19 and Overdose Health Emergencies in British Columbia, Canada, 2021.

Authors:  Ryan McNeil; Taylor Fleming; Samara Mayer; Allison Barker; Manal Mansoor; Alex Betsos; Tamar Austin; Sylvia Parusel; Andrew Ivsins; Jade Boyd
Journal:  Am J Public Health       Date:  2022-03-09       Impact factor: 9.308

3.  An Ethnographic Assessment of COVID-19‒Related Changes to the Risk Environment for People Who Use Drugs in Tijuana, Mexico.

Authors:  Joseph Friedman; Alhelí Calderón-Villarreal; Rebeca Cazares Adame; Daniela Abramovitz; Claudia Rafful; Gudelia Rangel; Alicia Vera; Steffanie A Strathdee; Philippe Bourgois
Journal:  Am J Public Health       Date:  2022-04       Impact factor: 9.308

4.  Evaluating disparities in prescribing of naloxone after emergency department treatment of opioid overdose.

Authors:  Scott G Weiner; Aleta D Carroll; Nicholas M Brisbon; Claudia P Rodriguez; Charles Covahey; Erin J Stringfellow; Catherine DiGennaro; Mohammad S Jalali; Sarah E Wakeman
Journal:  J Subst Abuse Treat       Date:  2022-04-30

5.  Medicaid professional fees for treatment of opioid use disorder varied widely across states and were substantially below fees paid by medicare in 2021.

Authors:  Lisa Clemans-Cope; Victoria Lynch; Maya Payton; Joshua Aarons
Journal:  Subst Abuse Treat Prev Policy       Date:  2022-07-06

6.  Xylazine spreads across the US: A growing component of the increasingly synthetic and polysubstance overdose crisis.

Authors:  Joseph Friedman; Fernando Montero; Phillippe Bourgois; Rafik Wahbi; Daniel Dye; David Goodman-Meza; Chelsea Shover
Journal:  Drug Alcohol Depend       Date:  2022-02-26       Impact factor: 4.852

7.  Fatal overdose: Predicting to prevent.

Authors:  Annick Borquez; Natasha K Martin
Journal:  Int J Drug Policy       Date:  2022-05-09

8.  The introduction of fentanyl on the US-Mexico border: An ethnographic account triangulated with drug checking data from Tijuana.

Authors:  Joseph Friedman; Philippe Bourgois; Morgan Godvin; Alfonso Chavez; Lilia Pacheco; Luis A Segovia; Leo Beletsky; Jaime Arredondo
Journal:  Int J Drug Policy       Date:  2022-04-11

9.  Surging Racial Disparities in the U.S. Overdose Crisis.

Authors:  Joseph Friedman; Leo Beletsky; Ayana Jordan
Journal:  Am J Psychiatry       Date:  2022-02       Impact factor: 18.112

10.  Addressing multiple overdoses: Opportunities for prevention and innovation.

Authors:  Sarah M Bagley; Scott E Hadland
Journal:  Int J Drug Policy       Date:  2021-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.